Literature DB >> 32583468

Clinical evaluation of three respiratory gating schemes for different respiratory patterns on cardiac SPECT.

Duo Zhang1, Jingzhang Sun1, P Hendrik Pretorius2, Michael King2, Greta S P Mok1,3.   

Abstract

PURPOSE: Respiratory gating reduces respiratory blur in cardiac single photon emission computed tomography (SPECT). It can be implemented as three gating schemes: (a) equal amplitude-based gating (AG); (b) phase or time-based gating (TG); or (c) equal count-based gating (CG), that is, a variant of amplitude-based method. The goal of this study is to evaluate the effectiveness of these respiratory gating methods for patients with different respiratory patterns in myocardial perfusion SPECT.
METHODS: We reviewed 1274 anonymized patient respiratory traces obtained via the Vicon motion-tracking system during their 99m Tc-sestamibi SPECT scans and grouped them into four breathing categories: (a) regular respiration (RR); (b) periodic respiration (PR); (c) respiration with apnea (AR); and (d) unclassified respiration (UR). For each respiratory pattern, 15 patients were randomly selected and their list-mode data were rebinned using the three gating schemes. A preliminary reconstruction was performed for each gate with the heart region segmented and registered to a reference gate to estimate the respiratory motion. A final reconstruction incorporating respiratory motion correction was done to get a final image set. The estimated respiratory motion, the full-width-at-half-maxima (FWHM) measured across the image intensity profile of the left ventricle wall, as well as the normalized standard deviation measured in a uniform cuboid region of the thorax were analyzed.
RESULTS: There are 47.1%, 24.3%, 13.5%, and 15.1% RR, PR, AR, and UR patients, respectively, among the 1274 patients in this study. The differences among the three gating schemes in RR were smaller than other respiratory patterns. The AG and CG methods showed statistically larger motion estimation than TG particularly in the AR and PR patterns. Noise of AG varied more in different gates, especially for AR and UR patterns.
CONCLUSION: More than half of the patients reviewed exhibited nonregular breathing patterns. Amplitude-based gating, that is, AG and CG, is a preferred gating method for such patterns and is a robust respiratory gating implementation method given the respiratory pattern of the patients is unknown before data acquisition. Phase gating is also a feasible option for regular respiratory pattern.
© 2020 American Association of Physicists in Medicine.

Entities:  

Keywords:  breathing pattern; cardiac SPECT; respiratory gating

Mesh:

Year:  2020        PMID: 32583468      PMCID: PMC7721994          DOI: 10.1002/mp.14354

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  28 in total

1.  Relative timing of inspiration and expiration affects respiratory sinus arrhythmia.

Authors:  G Strauss-Blasche; M Moser; M Voica; D R McLeod; N Klammer; W Marktl
Journal:  Clin Exp Pharmacol Physiol       Date:  2000-08       Impact factor: 2.557

2.  Data-driven respiratory motion tracking and compensation in CZT cameras: a comprehensive analysis of phantom and human images.

Authors:  Chi-Lun Ko; Yen-Wen Wu; Mei-Fang Cheng; Ruoh-Fang Yen; Wen-Chau Wu; Kai-Yuan Tzen
Journal:  J Nucl Cardiol       Date:  2014-08-14       Impact factor: 5.952

3.  Respiratory trace feature analysis for the prediction of respiratory-gated PET quantification.

Authors:  Shouyi Wang; Stephen R Bowen; W Art Chaovalitwongse; George A Sandison; Thomas J Grabowski; Paul E Kinahan
Journal:  Phys Med Biol       Date:  2014-02-07       Impact factor: 3.609

4.  Breathing patterns. 1. Normal subjects.

Authors:  M J Tobin; T S Chadha; G Jenouri; S J Birch; H B Gazeroglu; M A Sackner
Journal:  Chest       Date:  1983-08       Impact factor: 9.410

5.  Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability.

Authors:  A Mortara; P Sleight; G D Pinna; R Maestri; A Prpa; M T La Rovere; F Cobelli; L Tavazzi
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

6.  Evaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT images.

Authors:  Sang-June Park; Dan Ionascu; Joseph Killoran; Marcelo Mamede; Victor H Gerbaudo; Lee Chin; Ross Berbeco
Journal:  Phys Med Biol       Date:  2008-06-19       Impact factor: 3.609

7.  New Imaging Protocols for New Single Photon Emission CT Technologies.

Authors:  Piotr J Slomka; Daniel S Berman; Guido Germano
Journal:  Curr Cardiovasc Imaging Rep       Date:  2010-04-20

8.  The impact of respiratory motion on tumor quantification and delineation in static PET/CT imaging.

Authors:  Chi Liu; Larry A Pierce; Adam M Alessio; Paul E Kinahan
Journal:  Phys Med Biol       Date:  2009-11-20       Impact factor: 3.609

9.  Effect of novel amplitude/phase binning algorithm on commercial four-dimensional computed tomography quality.

Authors:  Jeffrey R Olsen; Wei Lu; James P Hubenschmidt; Michelle M Nystrom; Paul Klahr; Jeffrey D Bradley; Daniel A Low; Parag J Parikh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-26       Impact factor: 7.038

10.  Phase and amplitude binning for 4D-CT imaging.

Authors:  A F Abdelnour; S A Nehmeh; T Pan; J L Humm; P Vernon; H Schöder; K E Rosenzweig; G S Mageras; E Yorke; S M Larson; Y E Erdi
Journal:  Phys Med Biol       Date:  2007-05-18       Impact factor: 3.609

View more
  2 in total

1.  Pix2Pix generative adversarial network for low dose myocardial perfusion SPECT denoising.

Authors:  Jingzhang Sun; Yu Du; ChienYing Li; Tung-Hsin Wu; BangHung Yang; Greta S P Mok
Journal:  Quant Imaging Med Surg       Date:  2022-07

2.  Clinical evaluation of a novel atlas-based PET/CT brain image segmentation and quantification method for epilepsy.

Authors:  Ying Zhang; Duo Zhang; Zhaofeng Chen; Hongkai Wang; Weibing Miao; Wentao Zhu
Journal:  Quant Imaging Med Surg       Date:  2022-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.